
CCR1 inhibitor 19e
CAS No. 1220026-26-5
CCR1 inhibitor 19e( —— )
Catalog No. M10832 CAS No. 1220026-26-5
CCR1 inhibitor 19e is a novel potent, selective CCR1 antagonist with IC50 of 6.8 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 233 | Get Quote |
![]() ![]() |
50MG | 999 | Get Quote |
![]() ![]() |
100MG | 1449 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCCR1 inhibitor 19e
-
NoteResearch use only, not for human use.
-
Brief DescriptionCCR1 inhibitor 19e is a novel potent, selective CCR1 antagonist with IC50 of 6.8 nM.
-
DescriptionCCR1 inhibitor 19e is a novel potent, selective CCR1 antagonist with IC50 of 6.8 nM, inhibits CCR1chemotaxis in THP-1 cells with IC50 of 28 nM.
-
In VitroCCR1 antagonist 9 (Compound 19e) blocks the CCR1 chemotaxis of THP-1 cells with an IC50 of 28 nM. CCR1 antagonist 9 also blocks hERG with an IC50 of 30 μM.
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorChemokine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1220026-26-5
-
Formula Weight425.438
-
Molecular FormulaC20H16FN5O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 83.33 mg/mL (195.87 mM)
-
SMILESCS(=O)(=O)C1=NC=CC(=C1)CNC(=O)C2=CN=CC3=C2C=NN3C4=CC=C(C=C4)F
-
Chemical Name1-(4-fluorophenyl)-N-((2-(methylsulfonyl)pyridin-4-yl)methyl)-1H-pyrazolo[3,4-c]pyridine-4-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Harcken C, et al. Bioorg Med Chem Lett. 2018 Dec 13. pii: S0960-894X(18)30958-2. doi: 10.1016/j.bmcl.2018.12.024.
molnova catalog



related products
-
CCX140
A potent, selective, orally bioavailable CCR2 antagonist with Kd of 2.3 nM for hCCR2.
-
CMPD167
CMPD167 (MRK-1) is an orally acitve small molecule that binds to CCR5 to inhibit gp120 association.
-
FC131
FC131 (cyclo(-D-Tyr-Arg-Arg-Nal-Gly-)) is a selective, cyclopentapeptide CXCR4 antagonist with IC50 of 126 nM.